Kalejta R, Albright E
Front Cell Infect Microbiol. 2020; 10:95.
PMID: 32226778
PMC: 7080695.
DOI: 10.3389/fcimb.2020.00095.
Lee S, Lim J, Oh D, Park B, Park I, Choi H
Medicine (Baltimore). 2020; 99(12):e19568.
PMID: 32195966
PMC: 7220118.
DOI: 10.1097/MD.0000000000019568.
Xie K, Lambie E, Snyder M
Mol Cell Biol. 1993; 13(10):6170-9.
PMID: 8413218
PMC: 364676.
DOI: 10.1128/mcb.13.10.6170-6179.1993.
Bernstein R, Callender M, Neuberger J, Hughes G, Williams R
Ann Rheum Dis. 1982; 41(6):612-4.
PMID: 7149799
PMC: 1000995.
DOI: 10.1136/ard.41.6.612.
Wright J, Hughes P, ROWELL N
Ann Rheum Dis. 1982; 41(4):414-6.
PMID: 7114923
PMC: 1000961.
DOI: 10.1136/ard.41.4.414.
Spontaneous lymphocyte-mediated (NK cell) cytotoxicity in systemic sclerosis: a comparison with antibody-dependent lymphocyte (K cell) cytotoxicity.
Wright J, Hughes P, ROWELL N
Ann Rheum Dis. 1982; 41(4):409-13.
PMID: 7114922
PMC: 1000960.
DOI: 10.1136/ard.41.4.409.
Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis.
Bernstein R, Steigerwald J, Tan E
Clin Exp Immunol. 1982; 48(1):43-51.
PMID: 7044633
PMC: 1536562.
Autoantibody to centromere (kinetochore) in scleroderma sera.
Moroi Y, Peebles C, Fritzler M, Steigerwald J, Tan E
Proc Natl Acad Sci U S A. 1980; 77(3):1627-31.
PMID: 6966403
PMC: 348550.
DOI: 10.1073/pnas.77.3.1627.
Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response.
Kallenberg C, van der Voort-Beelen J, DAmaro J, The T
Clin Exp Immunol. 1981; 43(3):478-85.
PMID: 6945162
PMC: 1537173.
Monocyte-induced inhibition of lymphocyte response to phytohaemagglutinin in progressive systemic sclerosis.
Lockshin M, Markenson J, Fuzesi L, Kazanjian-Aram S, Joachim C, Ordene M
Ann Rheum Dis. 1983; 42(1):40-4.
PMID: 6600913
PMC: 1001057.
DOI: 10.1136/ard.42.1.40.
Cellular immunity in progressive systemic sclerosis (scleroderma).
Winkelstein A, Rodnan G, Heilman J
Ann Rheum Dis. 1972; 31(2):126-8.
PMID: 5016860
PMC: 1005879.
DOI: 10.1136/ard.31.2.126.
Rheumatoid factor in hypertension.
Ebringer A, Doyle A
Br Heart J. 1973; 35(3):334-7.
PMID: 4632567
PMC: 458610.
DOI: 10.1136/hrt.35.3.334.
Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.
Parker M, Kerby G
Ann Rheum Dis. 1974; 33(5):465-72.
PMID: 4608364
PMC: 1006307.
DOI: 10.1136/ard.33.5.465.
Patterns of nuclear fluorescence and DNA-binding activity.
Luciano A, Rothfield N
Ann Rheum Dis. 1973; 32(4):337-41.
PMID: 4580007
PMC: 1006112.
DOI: 10.1136/ard.32.4.337.
Immunological detection of nucleic acids and antibodies to nucleic acids and nuclear antigens by counterimmunoelectrophoresis.
Schur P, DeAngelis D, Jackson J
Clin Exp Immunol. 1974; 17(1):209-18.
PMID: 4549570
PMC: 1554045.
Scleroderma in childhood. Report of 5 cases.
Goel K, Shanks R
Arch Dis Child. 1974; 49(11):861-6.
PMID: 4441121
PMC: 1649218.
DOI: 10.1136/adc.49.11.861.
Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy.
Freundlich B, Jimenez S
Clin Exp Immunol. 1987; 69(2):375-84.
PMID: 3498592
PMC: 1542423.
Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100).
Szostecki C, Krippner H, Penner E, BAUTZ F
Clin Exp Immunol. 1987; 68(1):108-16.
PMID: 3308206
PMC: 1542698.
Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis.
Maddison P, Skinner R, Pereira R, Black C, ANSELL B, Jayson M
Ann Rheum Dis. 1986; 45(10):793-9.
PMID: 3098192
PMC: 1001999.
DOI: 10.1136/ard.45.10.793.
Scl-95/100: doublet of endothelial marker autoantigens in progressive systemic sclerosis.
Alderuccio F, Barnett A, Campbell J, Pedersen J, Toh B
Clin Exp Immunol. 1986; 64(1):94-100.
PMID: 3089652
PMC: 1542148.
